Michelle I Silver, William Klein, Goli Samimi, Lori Minasian, Jennifer Loud, Megan C Roberts. Breast Cancer Res Treat 2019
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.
Danielle S Chun, Brygida Berse, Vickie L Venne, Scott L DuVall, Kelly K Filipski, Michael J Kelley, Laurence J Meyer, Michael S Icardi, Julie A Lynch. Fam Cancer 2017
Danielle S Chun, Brygida Berse, Vickie L Venne, Scott L DuVall, Kelly K Filipski, Michael J Kelley, Laurence J Meyer, Michael S Icardi, Julie A Lynch. Fam Cancer 2017
66
Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
Min Yi, Kelly K Hunt, Banu K Arun, Isabelle Bedrosian, Angelica Gutierrez Barrera, Kim-Anh Do, Henry M Kuerer, Gildy V Babiera, Elizabeth A Mittendorf, Kaylene Ready,[...]. Cancer Prev Res (Phila) 2010
66
National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
33
BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer.
Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle. ESMO Open 2018
Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting, Lovise Mæhle. ESMO Open 2018
33
BRCA mutation genetic testing implications in the United States.
Soley Bayraktar, Banu Arun. Breast 2017
Soley Bayraktar, Banu Arun. Breast 2017
33
BRCA1/2 testing: therapeutic implications for breast cancer management.
Nadine M Tung, Judy E Garber. Br J Cancer 2018
Nadine M Tung, Judy E Garber. Br J Cancer 2018
33
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
Martin P Nilsson, Therese Törngren, Karin Henriksson, Ulf Kristoffersson, Anders Kvist, Barbro Silfverberg, Åke Borg, Niklas Loman. Breast Cancer Res Treat 2018
Martin P Nilsson, Therese Törngren, Karin Henriksson, Ulf Kristoffersson, Anders Kvist, Barbro Silfverberg, Åke Borg, Niklas Loman. Breast Cancer Res Treat 2018
33
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.
Pål Møller, Anne Irene Hagen, Jaran Apold, Lovise Maehle, Neal Clark, Bent Fiane, Kjell Løvslett, Eivind Hovig, Anita Vabø. Eur J Cancer 2007
Pål Møller, Anne Irene Hagen, Jaran Apold, Lovise Maehle, Neal Clark, Bent Fiane, Kjell Løvslett, Eivind Hovig, Anita Vabø. Eur J Cancer 2007
33
Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
33
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H Partridge, Judy E Garber. Breast Cancer Res Treat 2016
Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H Partridge, Judy E Garber. Breast Cancer Res Treat 2016
33
A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman. Value Health 2017
Anthony Eccleston, Anthony Bentley, Matthew Dyer, Ann Strydom, Wim Vereecken, Angela George, Nazneen Rahman. Value Health 2017
33
Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
33
Expanding the criteria for BRCA mutation testing in breast cancer survivors.
Janice S Kwon, Angelica M Gutierrez-Barrera, Diana Young, Charlotte C Sun, Molly S Daniels, Karen H Lu, Banu Arun. J Clin Oncol 2010
Janice S Kwon, Angelica M Gutierrez-Barrera, Diana Young, Charlotte C Sun, Molly S Daniels, Karen H Lu, Banu Arun. J Clin Oncol 2010
33
Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
Lucy Aitken, Linda Warwick, Alison Davis. Intern Med J 2017
Lucy Aitken, Linda Warwick, Alison Davis. Intern Med J 2017
50
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.
Christoph Engel, Kerstin Rhiem, Eric Hahnen, Sibylle Loibl, Karsten E Weber, Sabine Seiler, Silke Zachariae, Jan Hauke, Barbara Wappenschmidt, Anke Waha,[...]. BMC Cancer 2018
Christoph Engel, Kerstin Rhiem, Eric Hahnen, Sibylle Loibl, Karsten E Weber, Sabine Seiler, Silke Zachariae, Jan Hauke, Barbara Wappenschmidt, Anke Waha,[...]. BMC Cancer 2018
33
The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
Guan-Tian Lang, Jin-Xiu Shi, Xin Hu, Chen-Hui Zhang, Ling Shan, Chuan-Gui Song, Zhi-Gang Zhuang, A-Yong Cao, Hong Ling, Ke-Da Yu,[...]. Int J Cancer 2017
Guan-Tian Lang, Jin-Xiu Shi, Xin Hu, Chen-Hui Zhang, Ling Shan, Chuan-Gui Song, Zhi-Gang Zhuang, A-Yong Cao, Hong Ling, Ke-Da Yu,[...]. Int J Cancer 2017
33
Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.
Ka Keat Lim, Sook Yee Yoon, Nur Aishah Mohd Taib, Fatiha Hana Shabaruddin, Maznah Dahlui, Yin Ling Woo, Meow Keong Thong, Soo Hwang Teo, Nathorn Chaiyakunapruk. Appl Health Econ Health Policy 2018
Ka Keat Lim, Sook Yee Yoon, Nur Aishah Mohd Taib, Fatiha Hana Shabaruddin, Maznah Dahlui, Yin Ling Woo, Meow Keong Thong, Soo Hwang Teo, Nathorn Chaiyakunapruk. Appl Health Econ Health Policy 2018
33
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
Allison W Kurian, Kent A Griffith, Ann S Hamilton, Kevin C Ward, Monica Morrow, Steven J Katz, Reshma Jagsi. JAMA 2017
Allison W Kurian, Kent A Griffith, Ann S Hamilton, Kevin C Ward, Monica Morrow, Steven J Katz, Reshma Jagsi. JAMA 2017
33
Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.
Axel Muendlein, Bettina H Rohde, Klaus Gasser, Anton Haid, Stephanie Rauch, Elena Kinz, Heinz Drexel, Wera Hofmann, Verena Schindler, Rita Kapoor,[...]. J Cancer Res Clin Oncol 2015
Axel Muendlein, Bettina H Rohde, Klaus Gasser, Anton Haid, Stephanie Rauch, Elena Kinz, Heinz Drexel, Wera Hofmann, Verena Schindler, Rita Kapoor,[...]. J Cancer Res Clin Oncol 2015
33
A systematic review of factors that act as barriers to patient referral to genetic services.
Türem Delikurt, Graham R Williamson, Violetta Anastasiadou, Heather Skirton. Eur J Hum Genet 2015
Türem Delikurt, Graham R Williamson, Violetta Anastasiadou, Heather Skirton. Eur J Hum Genet 2015
33
Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
Amy Taylor, Angela F Brady, Ian M Frayling, Helen Hanson, Marc Tischkowitz, Clare Turnbull, Lucy Side. J Med Genet 2018
Amy Taylor, Angela F Brady, Ian M Frayling, Helen Hanson, Marc Tischkowitz, Clare Turnbull, Lucy Side. J Med Genet 2018
33
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Bent E Fiane, Turid Aas, Kathrine Woie, Helge Espelid, Tone Rusken, Hans Petter Eikesdal, Wenche Listøl, Marianne T Haavind,[...]. Eur J Hum Genet 2016
Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Bent E Fiane, Turid Aas, Kathrine Woie, Helge Espelid, Tone Rusken, Hans Petter Eikesdal, Wenche Listøl, Marianne T Haavind,[...]. Eur J Hum Genet 2016
33
Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
33
Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
33
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
Jingmei Li, Wei Xiong Wen, Martin Eklund, Anders Kvist, Mikael Eriksson, Helene Nordahl Christensen, Astrid Torstensson, Svetlana Bajalica-Lagercrantz, Alison M Dunning, Brennan Decker,[...]. Int J Cancer 2019
Jingmei Li, Wei Xiong Wen, Martin Eklund, Anders Kvist, Mikael Eriksson, Helene Nordahl Christensen, Astrid Torstensson, Svetlana Bajalica-Lagercrantz, Alison M Dunning, Brennan Decker,[...]. Int J Cancer 2019
33
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
Haitham W Tuffaha, Andrew Mitchell, Robyn L Ward, Luke Connelly, James R G Butler, Sarah Norris, Paul A Scuffham. Genet Med 2018
Haitham W Tuffaha, Andrew Mitchell, Robyn L Ward, Luke Connelly, James R G Butler, Sarah Norris, Paul A Scuffham. Genet Med 2018
33
BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Bárbara Alemar, Cleandra Gregório, Josef Herzog, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalas, Ida Vanessa D Schwartz, Jordy Coffa, Suzi Alves Camey, Jeffrey Weitzel,[...]. PLoS One 2017
Bárbara Alemar, Cleandra Gregório, Josef Herzog, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalas, Ida Vanessa D Schwartz, Jordy Coffa, Suzi Alves Camey, Jeffrey Weitzel,[...]. PLoS One 2017
33
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.
Martin P Nilsson, Christof Winter, Ulf Kristoffersson, Martin Rehn, Christer Larsson, Lao H Saal, Niklas Loman. Fam Cancer 2017
Martin P Nilsson, Christof Winter, Ulf Kristoffersson, Martin Rehn, Christer Larsson, Lao H Saal, Niklas Loman. Fam Cancer 2017
33
Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.
Cecelia A Bellcross, Lucy A Peipins, Frances A McCarty, Juan L Rodriguez, Nikki A Hawkins, Sharon Hensley Alford, Steven Leadbetter. Genet Med 2015
Cecelia A Bellcross, Lucy A Peipins, Frances A McCarty, Juan L Rodriguez, Nikki A Hawkins, Sharon Hensley Alford, Steven Leadbetter. Genet Med 2015
33
Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
33
Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.
Alexandra J van den Broek, Karen de Ruiter, Laura J van 't Veer, Rob A E M Tollenaar, Flora E van Leeuwen, Senno Verhoef, Marjanka K Schmidt. Eur J Hum Genet 2015
Alexandra J van den Broek, Karen de Ruiter, Laura J van 't Veer, Rob A E M Tollenaar, Flora E van Leeuwen, Senno Verhoef, Marjanka K Schmidt. Eur J Hum Genet 2015
33
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
33
Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
Lara Petelin, Alison H Trainer, Gillian Mitchell, Danny Liew, Paul A James. Genet Med 2018
Lara Petelin, Alison H Trainer, Gillian Mitchell, Danny Liew, Paul A James. Genet Med 2018
33
BRCA in breast cancer: ESMO Clinical Practice Guidelines.
J Balmaña, O Díez, I T Rubio, F Cardoso. Ann Oncol 2011
J Balmaña, O Díez, I T Rubio, F Cardoso. Ann Oncol 2011
33
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
33
Primary care physicians' use of family history for cancer risk assessment.
Brian S Flynn, Marie E Wood, Takamaru Ashikaga, Alan Stockdale, Greg S Dana, Shelly Naud. BMC Fam Pract 2010
Brian S Flynn, Marie E Wood, Takamaru Ashikaga, Alan Stockdale, Greg S Dana, Shelly Naud. BMC Fam Pract 2010
33
Use of BRCA Mutation Test in the U.S., 2004-2014.
Fangjian Guo, Jacqueline M Hirth, Yu-Li Lin, Gwyn Richardson, Lyuba Levine, Abbey B Berenson, Yong-Fang Kuo. Am J Prev Med 2017
Fangjian Guo, Jacqueline M Hirth, Yu-Li Lin, Gwyn Richardson, Lyuba Levine, Abbey B Berenson, Yong-Fang Kuo. Am J Prev Med 2017
33
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
P Pujol, D Stoppa Lyonnet, T Frebourg, J Blin, M C Picot, C Lasset, C Dugast, P Berthet, B Bressac de Paillerets, H Sobol,[...]. Breast Cancer Res Treat 2013
P Pujol, D Stoppa Lyonnet, T Frebourg, J Blin, M C Picot, C Lasset, C Dugast, P Berthet, B Bressac de Paillerets, H Sobol,[...]. Breast Cancer Res Treat 2013
33
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
33
Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
33
Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
D G R Evans, F Lalloo, A Wallace, N Rahman. J Med Genet 2005
D G R Evans, F Lalloo, A Wallace, N Rahman. J Med Genet 2005
33
Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.
Wei Xiong Wen, Jamie Allen, Kah Nyin Lai, Shivaani Mariapun, Siti Norhidayu Hasan, Pei Sze Ng, Daphne Shin-Chi Lee, Sheau Yee Lee, Sook-Yee Yoon, Joanna Lim,[...]. J Med Genet 2018
Wei Xiong Wen, Jamie Allen, Kah Nyin Lai, Shivaani Mariapun, Siti Norhidayu Hasan, Pei Sze Ng, Daphne Shin-Chi Lee, Sheau Yee Lee, Sook-Yee Yoon, Joanna Lim,[...]. J Med Genet 2018
33
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton, A C Antoniou. Br J Cancer 2014
33
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
Martin P Nilsson, Erik D Nilsson, Åke Borg, Yvonne Brandberg, Barbro Silfverberg, Niklas Loman. Breast Cancer Res Treat 2019
Martin P Nilsson, Erik D Nilsson, Åke Borg, Yvonne Brandberg, Barbro Silfverberg, Niklas Loman. Breast Cancer Res Treat 2019
33
Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.
. Br J Cancer 2000
. Br J Cancer 2000
33
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Katherine Clifton, Angelica Gutierrez-Barrera, Junsheng Ma, Roland Bassett, Jennifer Litton, Henry Kuerer, Stacy Moulder, Constance Albarracin, Gabriel Hortobagyi, Banu Arun. Breast Cancer Res Treat 2018
Katherine Clifton, Angelica Gutierrez-Barrera, Junsheng Ma, Roland Bassett, Jennifer Litton, Henry Kuerer, Stacy Moulder, Constance Albarracin, Gabriel Hortobagyi, Banu Arun. Breast Cancer Res Treat 2018
33
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
David M Euhus, Kristin C Smith, Linda Robinson, Amy Stucky, Olufunmilayo I Olopade, Shelly Cummings, Judy E Garber, Anu Chittenden, Gordon B Mills, Paula Rieger,[...]. J Natl Cancer Inst 2002
David M Euhus, Kristin C Smith, Linda Robinson, Amy Stucky, Olufunmilayo I Olopade, Shelly Cummings, Judy E Garber, Anu Chittenden, Gordon B Mills, Paula Rieger,[...]. J Natl Cancer Inst 2002
33
Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
33
Evaluating the NCCN Clinical Criteria for Recommending BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Caiqian Cropper, Ashley Woodson, Banu Arun, Carlos Barcenas, Jennifer Litton, Sarah Noblin, Diane Liu, Minjeong Park, Molly Daniels. J Natl Compr Canc Netw 2017
Caiqian Cropper, Ashley Woodson, Banu Arun, Carlos Barcenas, Jennifer Litton, Sarah Noblin, Diane Liu, Minjeong Park, Molly Daniels. J Natl Compr Canc Netw 2017
33
Time to Surgery and Breast Cancer Survival in the United States.
Richard J Bleicher, Karen Ruth, Elin R Sigurdson, J Robert Beck, Eric Ross, Yu-Ning Wong, Sameer A Patel, Marcia Boraas, Eric I Chang, Neal S Topham,[...]. JAMA Oncol 2016
Richard J Bleicher, Karen Ruth, Elin R Sigurdson, J Robert Beck, Eric Ross, Yu-Ning Wong, Sameer A Patel, Marcia Boraas, Eric I Chang, Neal S Topham,[...]. JAMA Oncol 2016
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.